Quest Diagnostics Debt to Equity Ratio 2010-2024 | DGX
Current and historical debt to equity ratio values for Quest Diagnostics (DGX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Quest Diagnostics debt/equity for the three months ending December 31, 2024 was 0.82.
| Quest Diagnostics Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-12-31 |
$9.34B |
$6.81B |
1.37 |
| 2024-09-30 |
$9.25B |
$6.84B |
1.35 |
| 2024-06-30 |
$7.23B |
$6.66B |
1.09 |
| 2024-03-31 |
$7.49B |
$6.47B |
1.16 |
| 2023-12-31 |
$7.68B |
$6.34B |
1.21 |
| 2023-09-30 |
$7.02B |
$6.46B |
1.09 |
| 2023-06-30 |
$7.14B |
$6.29B |
1.14 |
| 2023-03-31 |
$6.71B |
$6.09B |
1.10 |
| 2022-12-31 |
$6.91B |
$5.93B |
1.17 |
| 2022-09-30 |
$6.95B |
$6.27B |
1.11 |
| 2022-06-30 |
$6.86B |
$6.45B |
1.06 |
| 2022-03-31 |
$7.03B |
$6.42B |
1.10 |
| 2021-12-31 |
$7.13B |
$6.48B |
1.10 |
| 2021-09-30 |
$7.14B |
$6.43B |
1.11 |
| 2021-06-30 |
$6.92B |
$5.94B |
1.17 |
| 2021-03-31 |
$7.14B |
$6.79B |
1.05 |
| 2020-12-31 |
$7.22B |
$6.81B |
1.06 |
| 2020-09-30 |
$7.70B |
$6.45B |
1.19 |
| 2020-06-30 |
$7.11B |
$5.88B |
1.21 |
| 2020-03-31 |
$6.35B |
$5.70B |
1.11 |
| 2019-12-31 |
$7.16B |
$5.69B |
1.26 |
| 2019-09-30 |
$6.37B |
$5.65B |
1.13 |
| 2019-06-30 |
$6.25B |
$5.51B |
1.14 |
| 2019-03-31 |
$6.60B |
$5.34B |
1.24 |
| 2018-12-31 |
$5.74B |
$5.27B |
1.09 |
| 2018-09-30 |
$5.62B |
$5.37B |
1.05 |
| 2018-06-30 |
$5.48B |
$5.26B |
1.04 |
| 2018-03-31 |
$5.63B |
$5.07B |
1.11 |
| 2017-12-31 |
$5.55B |
$4.96B |
1.12 |
| 2017-09-30 |
$5.61B |
$4.83B |
1.16 |
| 2017-06-30 |
$5.44B |
$4.73B |
1.15 |
| 2017-03-31 |
$5.45B |
$4.66B |
1.17 |
| 2016-12-31 |
$5.44B |
$4.66B |
1.17 |
| 2016-09-30 |
$5.48B |
$4.69B |
1.17 |
| 2016-06-30 |
$5.54B |
$4.57B |
1.21 |
| 2016-03-31 |
$5.43B |
$4.67B |
1.16 |
| 2015-12-31 |
$5.25B |
$4.71B |
1.11 |
| 2015-09-30 |
$5.45B |
$4.62B |
1.18 |
| 2015-06-30 |
$5.38B |
$4.34B |
1.24 |
| 2015-03-31 |
$6.34B |
$4.27B |
1.49 |
| 2014-12-31 |
$5.53B |
$4.33B |
1.28 |
| 2014-09-30 |
$5.59B |
$4.21B |
1.33 |
| 2014-06-30 |
$5.64B |
$4.12B |
1.37 |
| 2014-03-31 |
$5.53B |
$4.02B |
1.38 |
| 2013-12-31 |
$4.98B |
$3.97B |
1.25 |
| 2013-09-30 |
$5.06B |
$3.87B |
1.31 |
| 2013-06-30 |
$5.10B |
$3.94B |
1.29 |
| 2013-03-31 |
$5.08B |
$4.23B |
1.20 |
| 2012-12-31 |
$5.10B |
$4.19B |
1.22 |
| 2012-09-30 |
$5.12B |
$4.20B |
1.22 |
| 2012-06-30 |
$5.37B |
$4.02B |
1.34 |
| 2012-03-31 |
$5.56B |
$3.90B |
1.43 |
| 2011-12-31 |
$5.60B |
$3.72B |
1.51 |
| 2011-09-30 |
$5.78B |
$3.55B |
1.63 |
| 2011-06-30 |
$5.98B |
$3.45B |
1.73 |
| 2011-03-31 |
$5.99B |
$3.24B |
1.85 |
| 2010-12-31 |
$4.47B |
$4.05B |
1.10 |
| 2010-09-30 |
$4.58B |
$3.88B |
1.18 |
| 2010-06-30 |
$4.54B |
$3.95B |
1.15 |
| 2010-03-31 |
$4.59B |
$3.93B |
1.17 |
| 2009-12-31 |
$4.55B |
$4.01B |
1.14 |
| 2009-09-30 |
$4.43B |
$3.94B |
1.12 |
| 2009-06-30 |
$4.45B |
$3.77B |
1.18 |
| 2009-03-31 |
$4.81B |
$3.53B |
1.36 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$19.317B |
$9.872B |
|
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
|
